Most patients who are interested in adipose tissue banking will want to discuss it with their primary care physician, specialist, or functional medicine provider before booking, and many will encounter a physician who is not yet familiar with the banking framework, the regulatory structure, or the current state of the ADSC clinical trial pipeline. This post gives you the language, the facts, and the framework to have that conversation clearly and confidently, including how to address common physician concerns about stem cell therapies in a way that distinguishes banking from the unregulated clinic sector. The goal is not to convince your doctor to prescribe banking. It is to have an informed, accurate conversation so you can make the best decision for your own health.
TLDR: Banking is a Section 361 HCT/P-compliant tissue preservation service, not a medical treatment and not an unregulated stem cell therapy. Your physician does not need to prescribe it, but their understanding of what it is, and what it is not, matters for your decision. This guide covers how to frame the conversation, how to address common physician concerns, what documentation to bring, and how to find a Save My Fat partner provider if your current physician is not in the network.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease. Banking is a tissue preservation service, not a medical treatment. This post is not medical advice and does not substitute for a conversation with a licensed physician who knows your health history. Physician consultation before the harvest procedure is appropriate for any patient with conditions that may affect the procedure or the harvest.
If you have done your research on banking, meaning you have read the evidence, understood the pipeline, and worked through the cost decision, and you want to talk to your doctor before booking, you are making a thoughtful decision. Your doctor’s familiarity with adipose tissue banking will vary widely depending on their specialty and how closely they follow regenerative medicine research. Many primary care physicians have not yet encountered banking in a clinical context. Some specialists, particularly in orthopedics, rheumatology, and functional medicine, are more likely to be familiar with the ADSC research landscape and may already have opinions about it.
The key framing to establish early in the conversation is that banking is tissue preservation, not stem cell treatment. Your doctor may have concerns about unregulated stem cell clinics, and those concerns are valid, because the FDA has taken enforcement action against clinics making false treatment claims for serious conditions. Banking under the Section 361 HCT/P framework is different in every material way. It is regulatory-compliant, it makes no treatment claims, and it preserves your own cells for potential future use under the same oversight framework that governs cord blood banking and other tissue preservation services.
This guide walks you through how to frame the conversation, what to bring to the appointment, how to address the most common physician responses, and what to do if your current physician is not a Save My Fat partner provider.
What Your Doctor Needs to Know About Banking
Banking Is Not a Stem Cell Treatment
The most important clarification to establish with any physician is that adipose tissue banking is tissue preservation under the FDA Section 361 HCT/P framework at 21 CFR Part 1271. It is the same regulatory category as cord blood banking. It makes no treatment claims. It does not involve injecting cells back into your body at the time of banking. It does not cure, treat, or prevent any disease. It preserves your own adipose-derived stem cells for potential future use in clinical trials, expanded access programs, or FDA-approved therapies as they develop. Save My Fat’s overviews of FDA regulations for adipose tissue and 21 CFR Part 1271 cover the regulatory framework in physician-appropriate depth if your doctor wants more detail.
The Harvest Procedure
The banking harvest is a thirty-minute outpatient procedure performed under local anesthesia by a trained Save My Fat partner provider. A small-bore cannula removes a small volume of adipose tissue from the abdomen or flank. No general anesthesia is required. Most patients return to normal activity the same day or the next day. The physician performing the harvest is typically a plastic surgeon, aesthetic physician, or other appropriately trained Save My Fat partner provider, not the patient’s primary care physician unless that physician is also a Save My Fat partner.
The role of your existing physician in the banking process is typically to understand what banking is, to review your medical history for any contraindications to a minor outpatient procedure, and to be available for follow-up if you have post-procedure questions. Save My Fat’s overview of how banking works covers the full patient-facing process.
The Science in Brief
If your physician wants to understand the scientific basis for banking, the core points are compact enough to cover in a short conversation.
Adipose tissue contains adipose-derived stem cells, a subpopulation of mesenchymal stem cells with documented multipotent differentiation capacity and paracrine immunomodulatory activity, as the 2019 MSC biology review from Pittenger and colleagues in npj Regenerative Medicine documents.
More than four hundred active clinical trials on ClinicalTrials.gov are investigating ADSC and MSC applications in orthopedic, autoimmune, neurological, and aesthetic conditions, with the orthopedic evidence base being the most clinically advanced category.
The FDA approved the first MSC-based biologic, Ryoncil, in December 2024 for steroid-refractory acute graft-versus-host disease, which is listed in the FDA approved cellular and gene therapy products database. This approval established the regulatory precedent that MSC-based therapies can clear the full approval pathway.
ADSC biological quality, including proliferative capacity and differentiation potential, declines with age and disease, which makes early preservation the logical strategy for patients considering future access. Save My Fat’s comparison of mesenchymal stem cells across sources covers this background in patient-accessible depth for physicians who want a quick orientation.
How to Frame the Conversation
Start with What You Want From the Conversation
Be direct about what you are asking for. Most patients want one of three things from the banking conversation with their physician.
- A general discussion: “I want your perspective on whether banking makes sense given my health history.”
- A medical history review: “I want to make sure there are no contraindications in my health history before I book a harvest procedure.”
- A referral or recommendation: “Is there a Save My Fat partner provider you can refer me to, or are you aware of any reason I shouldn’t proceed?”
Opening the conversation with a clear ask makes it more efficient and reduces the chance of the discussion getting derailed by general skepticism about stem cell therapies before the banking-specific framework is established. A physician who does not know what you are asking for will default to general caution, which often reads as discouragement even when the physician’s actual medical view is neutral or supportive.
Bring the Right Materials
Consider bringing or sharing in advance Save My Fat’s overview of how banking works, the regulatory explainer on 21 CFR Part 1271, the patient resource on questions to ask before banking, and a printed or linked copy of this post as a conversation reference. Physicians who are unfamiliar with banking often need five minutes of context to distinguish it from unregulated stem cell clinics. Having the materials ready shortens that orientation significantly and makes the conversation more productive for both of you.
How to Address Common Physician Concerns
“I Don’t Think Stem Cell Therapies Are Proven”
This is a valid concern about a different category of service. Acknowledge it directly, then reframe the conversation on banking specifically. Sample language: “I understand there are a lot of unregulated stem cell clinics making claims that aren’t backed by evidence. Banking is different. It is tissue preservation under the FDA Section 361 framework, not a treatment. It doesn’t claim to cure or treat anything. It is comparable to cord blood banking, which is preserving cells for potential future use as the evidence and approvals develop.”
Then reference the December 2024 Ryoncil approval as evidence that the FDA-regulated pathway does work. The first MSC product has been approved for a serious immune condition, and the broader pipeline is building toward the same standard under the same regulatory framework. Save My Fat’s comparison of banking vs. stem cell treatment clinics covers the distinction in more depth if the physician wants a reference.
“I’ve Heard Bad Things About Stem Cell Clinics”
A natural response from a physician who has seen FDA warning letters or patient harm from unregulated clinics. The correct response is agreement, not defense. Sample language: “You’re right to be skeptical of those clinics. The FDA has taken enforcement action against clinics making false treatment claims for ALS, Parkinson’s, and other serious conditions. That’s exactly why I’m using a compliant banking service rather than going to one of those clinics. Banking doesn’t involve any treatment claims. It just preserves my cells for future use under the regulatory framework at 21 CFR Part 1271 that governs tissue preservation.”
This response validates the physician’s concern, establishes alignment on the issue of predatory clinics, and then uses that alignment to position banking as the compliant alternative rather than as part of the problem. Save My Fat’s resource on fake stem cell clinic red flags is a useful follow-up reference for the physician who wants to understand the distinction in more detail.
“I’m Not Sure This Is Worth the Cost”
This is an opinion, not a medical concern, and your physician is entitled to it. Acknowledge it without defending the cost decision. Sample language: “I appreciate the perspective. I’ve thought through the cost decision carefully and feel that the option value of banking now, while my cells are at their best quality, makes sense for me given my family history of joint disease. I’m not asking you to endorse the financial decision. I just want to make sure there are no medical contraindications before I proceed.”
Separating the financial opinion from the medical review keeps the conversation on the relevant track. Your physician’s role in the banking conversation is medical contraindication review, not financial counseling, and gently redirecting to the medical question is both respectful and efficient.
“What Would You Use the Cells For?”
A fair and often genuinely curious question. Answer with specificity tied to your own health history. Sample language: “The main applications being developed are orthopedic for joints, autoimmune, and neurological. Given my joint health history and family pattern of early osteoarthritis, the orthopedic pipeline is particularly relevant to me. Banking now preserves the option to access those trials and approvals as they develop.”
Having a specific answer tied to your health history makes the conversation more concrete and shows your research is grounded in relevant applications rather than general hope. The active ADSC trial pipeline on ClinicalTrials.gov covers the full landscape for a physician who wants to browse the active studies in any specific indication area, and Save My Fat’s patient-facing introduction to adipose-derived stem cells covers the underlying biology in accessible terms.
If Your Physician Is Not a Save My Fat Partner
Many patients’ primary care physicians or specialists will not be Save My Fat partner providers. That is completely normal. The harvest procedure is performed by a trained Save My Fat partner provider, not by the patient’s existing physician. Your existing physician’s role is medical review and conversation, not the procedure itself, and there is no expectation that every patient’s primary care physician will also be a banking provider.
To find a Save My Fat partner provider for the harvest, Save My Fat’s provider program overview is the starting point. If your physician is interested in becoming a Save My Fat partner provider and wants to learn about the partner network, the partner sign-up page is the appropriate resource.
For Physicians Reading This Post
If a patient shared this post with you, here is a brief orientation to the framework your patient is describing.
Adipose tissue banking under the Save My Fat program is a Section 361 HCT/P tissue preservation service governed by 21 CFR Part 1271. It is performed by trained partner providers under a compliant chain-of-custody protocol. The harvested tissue is processed and cryopreserved by L2 Bio, an FDA-registered tissue establishment.
Banking makes no treatment claims and is not a medical procedure in the sense of treating a specific condition. It is analogous to cord blood banking. It is elective, cash-pay, regulatory-compliant tissue preservation for potential future use in FDA-regulated pathways as they mature.
If your patient is in good general health and has no contraindications to a minor outpatient procedure under local anesthesia, there is no medical basis for discouraging banking from a safety standpoint. Whether it makes sense for a given patient is a discussion worth having, because cost and individual health context are both legitimate factors. The science and the regulatory framework support banking as a legitimate option for patients who want to preserve autologous cells ahead of the maturing clinical trial pipeline.
For a full clinical overview of the provider program, the Save My Fat provider page covers the partner framework. For the regulatory structure, the 21 CFR Part 1271 explainer covers the HCT/P framework in physician-appropriate depth. For patients with serious conditions who may qualify for expanded access to investigational MSC products, the Reagan-Udall Foundation’s Expanded Access Navigator is the appropriate federal resource, and Save My Fat’s overview of expanded access programs covers the patient-facing framework.
Key Takeaways
Banking is tissue preservation under Section 361 HCT/P, not a stem cell treatment. Establishing that distinction early is the single most important step in the physician conversation, because most physician skepticism about stem cells is actually skepticism about unregulated clinics rather than about preservation services, and the two categories are genuinely different.
The physician’s role in banking is medical history review and contraindication assessment rather than performing the harvest. The harvest is performed by a trained Save My Fat partner provider, typically a plastic surgeon or aesthetic physician with existing fat harvesting experience. Your existing physician does not need to be in the Save My Fat network for you to proceed.
Three common physician concerns have clear responses. Stem cell skepticism is addressed by distinguishing banking from treatment. Clinic concerns are addressed by aligning with the physician on unregulated clinics and positioning banking as the compliant alternative. Cost skepticism is addressed by separating the financial opinion from the medical review, and redirecting to the relevant question of contraindications.
Bring or share supporting materials with the conversation. The regulatory explainer, the how-it-works page, and the question guide together give a physician the five minutes of context needed to engage productively. Most physicians will shift from generalized caution to focused assessment once the framework is clear, and the materials do that work efficiently.
If your physician is not a Save My Fat partner, that is normal and expected. Use the Save My Fat provider resources to locate the partner provider who will perform the harvest. Your existing physician’s role is consultation and review, and many patients will see two physicians through the banking process: their existing primary care physician or specialist for the medical review, and a Save My Fat partner provider for the harvest itself.
The physician who reads the final section of this post may become a Save My Fat provider inquiry. The post is designed to serve both audiences simultaneously, and a physician who is unfamiliar with the banking framework but interested in the science may find the partner program worth evaluating for their own practice.
Ready to Find a Provider?
Before moving forward: adipose tissue banking is a preservation service for potential future use in FDA-regulated pathways, not a treatment or a guarantee of access to any specific clinical trial, therapy, or product. No adipose-derived product is FDA-approved for general disease treatment, and banking cannot be represented as a treatment for any condition. Consult your physician about whether banking is appropriate for your specific situation. Physicians considering partnership should independently verify applicable state licensing and informed-consent requirements, particularly in Florida, Utah, and Nevada, which have stem cell-specific statutes.
To find a Save My Fat partner provider near you, visit the provider overview. To prepare your questions before the conversation, visit the resource on questions to ask before banking. For physicians interested in the partner program, the partner sign-up page is the starting resource.
Save My Fat provides adipose tissue banking services in partnership with L2 Bio for laboratory operations. Save My Fat does not provide medical treatments, clinical trial enrollment, or Expanded Access services.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including neurology and neurosurgery input is required before publication. Please consult your neurologist or neurosurgeon before making any decisions about neurologic treatment or research participation.
